Back to Search
Start Over
Seattle Genetics and Pieris Pharmaceuticals Announce Multi-Program Immuno-Oncology Collaboration
- Source :
- Biotech Business Week. February 19, 2018, 169
- Publication Year :
- 2018
-
Abstract
- 2018 FEB 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its [...]
- Subjects :
- Seagen Inc. -- Licensing agreements
Licensing agreements
Company licensing agreement
Cancer treatment
Biotechnology industries -- Licensing agreements
Antibodies
Biological products industry -- Licensing agreements
Proteins
Biotechnology industry -- Licensing agreements
Viral antibodies
Cancer -- Care and treatment
Subjects
Details
- Language :
- English
- ISSN :
- 1543687X
- Database :
- Gale General OneFile
- Journal :
- Biotech Business Week
- Publication Type :
- News
- Accession number :
- edsgcl.527985617